Khara Rahul sold $527K of IRON
Khara Rahul (Chief Legal Officer) sold 7,500 shares of Disc Medicine, Inc. (IRON) at an average of $70.22 ($69.94–$71.62, $0.53M total) across 3 trades on 2026-06-18 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the CLO’s open-market sale details (shares, price range, total value) and that it was executed under a pre-arranged 10b5-1 plan.
Market read
Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a durable repricing without additional company-specific catalysts.
What to watch
The article doesn’t state whether the insider’s remaining holdings changed materially beyond the post-transaction share count, nor does it provide context on prior sales or compensation-driven liquidity needs.
Background
The article is an SEC Form 4 insider transaction disclosure for Disc Medicine, Inc. (IRON).
Ticker impact
Disc Medicine’s C-suite (Chief Legal Officer) sold 7,500 shares in open-market trades under a pre-arranged 10b5-1 plan, filed June 23.
Likely limited near-term impact; any effect would be sentiment-driven and should fade unless followed by additional disclosures.
The filing is a routine 10b5-1 sale with specified trade dates/prices and no accompanying operational or guidance change in the text.
Market effects
No sector read-through is provided; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may be mechanically scheduled and not a signal of deteriorating fundamentals.
Key entities
- issuerDisc Medicine, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderKhara Rahul
Chief Legal Officer who sold shares in open-market trades under a 10b5-1 plan.